Navigation Links
Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
Date:11/26/2008

SAN DIEGO, Nov. 26 /PRNewswire/ -- Ceregene, Inc., a biopharmaceutical company, today reported clinical data from a double-blind, controlled Phase 2 trial of CERE-120 in 58 patients with advanced Parkinson's disease. The trial did not demonstrate an appreciable difference between patients treated with CERE-120 versus those in the control group. Both groups showed an approximate 7 point improvement in the protocol-defined primary endpoint (Unified Parkinson's Disease Rating Scale- motor off score at 12 months), relative to a mean at baseline of approximately 39 points. Both groups had a substantial number of patients who demonstrated a meaningful clinical improvement from baseline. CERE-120 appeared to be safe and well tolerated.

"On behalf of everyone at Ceregene, I would like to personally express my gratitude to all the patients, physicians and staff who participated in this study. We share their disappointment. We also offer our heartfelt appreciation to the many talented and dedicated employees at Ceregene who continue to work extremely hard on this and Ceregene's other programs," stated Jeffrey M. Ostrove, Ph.D., president and chief executive officer of Ceregene. "We continue to believe in the multiple opportunities in our pipeline that target a range of serious neurodegenerative and ocular diseases."

"The medical research community has for several decades attempted to use the unique healing properties of neurotrophic factors to treat serious neurodegenerative diseases, and Ceregene's use of gene therapy as an essential enabling technology to translate this idea into an effective human therapeutic has consistently generated strong empirical support," stated Raymond T. Bartus, Ph.D., Ceregene's executive vice president and chief scientific officer. "Thus, we are stunned by the results of this trial and will continue to analyze the data in order to gain greater insight into the factors that may have contr
'/>"/>

SOURCE Ceregene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Ceregene Appoints Joao Siffert, M.D. to the Position of Chief Medical Officer
2. Ceregene Announces Two Key Additions to Leadership Team
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., LONDON, November 30 ApaTech,...amed Europe,s fastest growing,Biotech/Pharmaceutic...oitte,2009 Technology Fast 500 for EMEA (Europe, M...king is based on a companies, five-year revenue gr...18% over this period. This,achievement places ApaT...
(Date:11/29/2009)...available in German . , The concept of conf...ics. The most famous example is that of quarks whi... Prof. Bella Lake from Helmholtz-Zentrum Berlin to...port for the first time an experimental realizatio...n a condensed matter system. , The concept of co...
(Date:11/27/2009)...URHAM, N.C., Nov. 27 Cromoz Inc., ...ater-soluble carbon nanotube-based cancer drug del...e carbon nanotubes, which have functional groups o...r drugs, was developed in partnership with the Ind...on nanotubes serves as a drug delivery vehicle wit...
(Date:11/27/2009)... A mechanised blue dye test alternative is...ality assurance one step closer for pharma-compani...ting machine developed by Sepha for use with bl...everal local and global pharma-companies such as S...assurance and productivity improvements on the pac...
Breaking Biology Technology:ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4Spinons -- confined like quarks 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3
... therapeutic areas to pharmaceutical and ...ggressive acquisition strategy over the last year,...l,Trials, Inc.("WCT"), formed by Dr. Neal R. Cutle...ne in establishing itself as a premier global,cont...hat it has closed the,acquisition of MediQuest, a ...
...gn of things to come, NEWARK, N.J., July 9 Anxie...than among healthcare workers, who by some estimat...f on-the-job violence than,their counterparts in o...eam of horrific headlines, healthcare facilities u...eir employees, says LeClairRyan,s Joseph P.,Parana...
... /Xinhua-PRNewswire-FirstCall/ --,China Biologic P...r the,"Company"), one of the leading plasma-based ...of China ("PRC"), today announced that the Company... plasma collection station in,Qi He County, Shando...tion has a daily capacity to collect human plasma ...
Other Biology Technology:Worldwide Clinical Trials Emerges as Leading Global Contract Research Organization 2Worldwide Clinical Trials Emerges as Leading Global Contract Research Organization 3Healthcare Industry Faces Mounting Pressure to Prevent On-The-Job Violence, Says Veteran Safety and Health Attorney 2China Biologic Products Begins Operation of its Newly Constructed Plasma Collection Station in Qi He County, Shandong Province 2China Biologic Products Begins Operation of its Newly Constructed Plasma Collection Station in Qi He County, Shandong Province 3
(Date:11/30/2009)...ished in the December 2009 print issue of The FAS... control over their fertility that women have had ...und how and where androgenic hormones work in the ... fertility. This opens a promising avenue for the ...lso offers hope to those who cannot have children ...
(Date:11/26/2009)...e antlers, red deer have been caught in the hunter...e much more than decorative. They are lethal weapo...urrey, from The University of York, UK, has been i...over half a century and has become fascinated by t...standing collaboration with Tomas Landete-Castille...
(Date:11/26/2009)...r 2009 What are the bare essentials of life, the ...ll that can survive on its own? Can we describe th...an entire organism functions as a system? These ar...partnership between the European Molecular Biology... Centre de Regulacio Genmica (CRG) in Barcelona, S...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Landrieu Snowe Convene Roundtable on Healthcare for Small Businesses 51248 1Landrieu Snowe Convene Roundtable on Healthcare for Small Businesses 51248 2Landrieu Snowe Convene Roundtable on Healthcare for Small Businesses 51248 3Neogen Named to Fortunes List of Fastest Growing Companies 12961 1Neogen Named to Fortunes List of Fastest Growing Companies 12961 2Corgenix to Exhibit AspirinWorks 28R 29 Test at 2009 ISTH Meeting 51243 1Corgenix to Exhibit AspirinWorks 28R 29 Test at 2009 ISTH Meeting 51243 2Corgenix to Exhibit AspirinWorks 28R 29 Test at 2009 ISTH Meeting 51243 3
... reducing vascular aging by inactivating TNFa, whi... cell death. The related report by Csiszar et al....t in aging," appears in the January issue of The A...ar diseases, including high blood pressure, heart ...ise healthy individuals. Advanced age is also ass...
... Hospital have discovered in mouse models how cell... cause fatal heart damage; researchers have also s... damage by increasing the number of cell wall piec...ted in a mouse model how to prevent this from happ... from Streptococcus pneumoniae bacteria "hijack" a...
... Lane and Victoria VanderNoot have been awarded a ...ccessfully detect deadly toxins from harmful algal...perative Institute for Coastal and Estuarine Envir... National Oceanic and Atmospheric Administration (...and VanderNoot, a molecular biologist and an analy...
Other Biology News:A new jump start for aging blood vessels 2Cell wall of pneumonia bacteria can cause brain and heart damage 2Cell wall of pneumonia bacteria can cause brain and heart damage 3Sandia research to focus on early detection of harmful algal blooms 2Sandia research to focus on early detection of harmful algal blooms 3
Xpression Primer from PREMIER Biosoft International
HybriWell™ hybridization sealing system, 22 mm x 22 mm chamber, 0.15 mm deep *set of 100* from Molecular Probes (Invitrogen)
Equine IL-6, Unconjugated from R&D Systems
Feline IL-2, Unconjugated from R&D Systems
Biology Products: